DRUG Stock Performance and Key Statistics

DRUG has a current P/E ratio of -67.79

The DRUG stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 12.75.

DRUG's price-to-free-cashflow (P/FCF) ratio is -97.88, an indicator that is currently being trending upward.

Based on DRUG's recent bid, its distance from 20 days simple moving average is -9.07%. It is -7.26% apart from 50 days simple moving average, and it is 48.14% apart from 200 days simple moving average.

The 52-week high for DRUG is $123.75 which is -38.61% away from the current price level whereas the distance of that from the 52-week low of $23.18 stands at 227.81%.

The performance of DRUG stock was not encouraging with most of its significant price indicators in green. Bright Minds Biosciences Inc.(NASDAQ: DRUG) shares have moved upward +3.95% or $2.89 in the latest trading session and have gained 6.36% year-to-date (YTD). The stock has gained nearly 126.78% over the past year. After moving 31.45% over the trailing 3-month period, the stock is 217.52% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -6.39% a week and -5.77% a month.

The current 14-day RSI for DRUG stock is 42.67. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Bright Minds Biosciences Inc. (DRUG) has a 14-day ATR of 6.25.

After closing at $73.08 with 7.79M of its shares outstanding, the current enterprise value of DRUG is roughly -176.18K.

Bright Minds Biosciences Inc. (NASDAQ: DRUG) is up 126.78% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 8.57%. DRUG stock price is also up 6.36% on its value in year-to-date trading.

The number outstanding shares of DRUG is 7.79M, and of these 69.63% shares are freely available for trading. On average, DRUG stock has traded 143.89K shares per day for the past 10 days. A total of 115.01K shares changed hands during the last trading session with the average session volume of 203.17K shares.